相关实验视频

Updated: Jun 12, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

艾米齐祖马布治疗严重血友病A型儿童

Usha Rani Thota¹, Sreelatha Martha¹, Chaitanya Jyothi Ravula¹

¹Department of Pediatrics, Institute of Child Health - Niloufer Hospital for Women and Children, Osmania Medical College, Hyderabad, Telangana, India.

Indian journal of pediatrics

|September 25, 2024

概括

艾米齐祖马布预防可显著减少严重血友病A (HA) 的儿童的出血事件. 这种新的非因子替代疗法显示出高效和安全性,改善了患者的生活质量.

科学领域:

血液学血液学血液学
儿科医学儿科医学
药理学药理学是指药理学的学科.

背景情况:

血友病A (HA) 是一种罕见的出血疾病,其特点是 VIII 凝固因子的缺乏.
目前对HA的治疗包括因子替代疗法和免疫耐受性诱导,这在某些患者中可能是繁重和不太有效的.
艾米齐祖马布代表了一种新的治疗方法,作为HA管理的非因子替代剂.

研究的目的:

评估埃米齐祖马布在重度血友病A型儿科患者的预防中的疗效和安全性.
评估埃米齐祖马布对出血事件发生率和关节健康的影响.
为了确定艾米齐祖马布在这个人群中的耐受性和不良事件概况.

主要方法:

采用了观察性,前后研究设计.
纳入了18名患有严重HA的儿科患者 (1个月至12岁),有或没有XVIII因子抑制剂.
患者从以前的疗法过渡到埃米齐祖马布预防治疗,并被跟踪52周.

主要成果:

平均年均出血率从埃米齐祖马布前的12.7事件大幅下降到预防后的0.28事件 (p < 0.001).
72.2%的患者在接受埃米齐祖马布预防治疗期间没有出现出血事件.
年均关节出血率显著降低,目标关节解决率为100%,没有报告的不良事件.

结论:

埃米齐祖马布是一种有效和安全的预防性治疗严重的血友病A,包括在患有第八因子抑制剂的患者中.
艾米齐祖马布预防提供了一种有前途的策略,以优化治疗结果,提高严重HA儿童的生活质量.

关键词:

双特异性抗体双特异性抗体艾米奇祖马布 (Emicizumab) 是一种药物.第八个因子血友病A型血友病A型血友病儿科儿科儿科

更多相关视频

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...